Thirty Years After First Test Tube Baby, Scientists Pursue Healthier Human Embryo
LEXINGTON, Mass., July 22 /PRNewswire/ — On the 30th anniversary of the birth of the world’s first “test tube baby,” Louise Brown of England, embryologists at one of the nation’s largest in vitro fertilization (IVF) clinics are conducting a clinical study aimed at the pursuit of a healthier human embryo with dramatically increased chances of full gestation to birth of a healthy baby.
This month the Reproductive Science Center of New England partners with Molecular Biometrics, a privately-held company developing diagnostic tools to characterize biologic function in health and disease, to begin a clinical study of a process known as metabolomic profiling, an advanced means of assessing embryo viability.
Success of the study may hold out hope that doctors can succeed in identifying a single embryo with excellent chances of a full pregnancy. Due to a multitude of chromosomal abnormalities which exist in most embryos, a significant number of embryos do not implant successfully. Many others spontaneously miscarry very soon following implantation, as occurs frequently in cases of naturally conceived pregnancies.
Traditionally, in vitro fertilization (IVF) specialists have improved the odds by transferring more than one embryo to a woman’s uterus, a practice that doctors are moving away from because it increases the chances of high-order multiple births and accompanying health risks to both mother and child.
“Ideally, by improving the process of embryo selection, we can reduce multiple births and optimize birth outcomes,” said Dr. Kathryn Go, laboratory director of RSC New England.
To learn more, please visit http://www.rscnewengland.com/. About RSC New England
With 11 locations throughout New England, Reproductive Science Center is the seventh largest medical practice of its kind nationwide, known coast to coast for its innovative patient care, advanced laboratory capabilities and for success rates that are among the highest in the U.S. Founded in 1988, RSC is led today by a team of six physicians — four of whom are women, making it one of the largest groups of female reproductive endocrinologists in the Northeast. RSC is a member of IntegraMed, a national network of 32 fertility centers in 104 locations across the U.S., including 185 physicians and Ph.D. scientists. Nearly one of every four IVF procedures in the U.S. are performed in an IntegraMed fertility practice. For more information, visit http://www.rscnewengland.com/.
RSC New England
CONTACT: Rick Dietz of RSC New England, 1-800-858-4832; or Jordan Peel,or Ron King, both of Vanguard Communications, 1-877-382-2999, for RSC NewEngland
Web site: http://www.rscnewengland.com/